Skip to main content
logo white
Off canvas

Nasal Spray Flu Vaccine Not to be Used This Season

The Centers for Disease Control and Prevention (CDC) has announced that live attenuated influenza vaccine (LAIV), or “nasal spray” flu vaccine, should not be used this upcoming flu season. The decision came from a vote from CDC’s Advisory Committee on Immunization Practices (ACIP), an immunization expert advisory panel. ACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV), for everyone 6 months and older.

The decision was based on data from the previous three flu seasons that showed almost no protective benefit of LAIV. LAIV typically supplies about 8 percent of the total projected flu vaccine supply. It is expected that at least 157 million doses of injectable vaccine will be available in the United States this season. Read CDC Media Statement
Add comment
  • No comments found